ORAI1 Antikörper (N-Term)
Kurzübersicht für ORAI1 Antikörper (N-Term) (ABIN635032)
Target
Alle ORAI1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- ORAI1 antibody was raised against the N terminal of ORAI1
-
Aufreinigung
- Affinity purified
-
Immunogen
- ORAI1 antibody was raised using the N terminal of ORAI1 corresponding to a region with amino acids HPEPAPPPSRSSPELPPSGGSTTSGSRRSRRRSGDGEPPGAPPPPPSAVT
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
ORAI1 Blocking Peptide, (ABIN939195), is also available for use as a blocking control in assays to test for specificity of this ORAI1 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ORAI1 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- ORAI1 (ORAI Calcium Release-Activated Calcium Modulator 1 (ORAI1))
-
Andere Bezeichnung
- ORAI1
-
Hintergrund
- ORAI1 belongs to the Orai family. ORAI1 (CRACM1) is a plasma membrane protein essential for store-operated calcium entry. Defects in ORAI1 are a cause of severe combined immunodeficiency with CRAC channel dysfunction.
-
Molekulargewicht
- 33 kDa (MW of target protein)
-
Pathways
- T-Zell Rezeptor Signalweg, BCR Signaling
Target
-